Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lnc-LRRTM4 promotes proliferation, metastasis and EMT of colorectal cancer through activating LRRTM4 transcription. | Cancer Cell Int | 2023 | 37468908 | PubTator, text mining | PubMed |
| Icariin as a potential anticancer agent: a review of its biological effects on various cancers. | Front Pharmacol | 2023 | 37456751 | PubTator, text mining | PubMed |
| Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance. | Front Genet | 2023 | 37456663 | PubTator, text mining | PubMed |
| circRPS19 affects HK2‑mediated aerobic glycolysis and cell viability via the miR‑125a‑5p/USP7 pathway in gastric cancer. | Int J Oncol | 2023 | 37449524 | PubTator, text mining | PubMed |
| Mapping genetic variants for nonsense-mediated mRNA decay regulation across human tissues. | Genome Biol | 2023 | 37434206 | PubTator, text mining | PubMed |
| Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management. | Cancer Manag Res | 2023 | 37426392 | PubTator, text mining | PubMed |
| Underlying mechanisms and clinical potential of circRNAs in glioblastoma. | Oncol Res | 2023 | 37415736 | PubTator, text mining | PubMed |
| Intronic small nucleolar RNAs regulate host gene splicing through base pairing with their adjacent intronic sequences. | Genome Biol | 2023 | 37415181 | PubTator, text mining | PubMed |
Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197. | FEBS Open Bio | 2023 | 37410095 | PubTator, text mining | PubMed |
| A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer. | Mol Cancer | 2023 | 37408008 | PubTator, text mining | PubMed |
| Nuclear mRNPs are compact particles packaged with a network of proteins promoting RNA-RNA interactions. | Genes Dev | 2023 | 37399331 | PubTator, text mining | PubMed |
| Gene SH3BGRL3 regulates acute myeloid leukemia progression through circRNA_0010984 based on competitive endogenous RNA mechanism. | Front Cell Dev Biol | 2023 | 37397256 | PubTator, text mining | PubMed |
| Exosome-derived circKIF20B suppresses gefitinib resistance and cell proliferation in non-small cell lung cancer. | Cancer Cell Int | 2023 | 37394466 | PubTator, text mining | PubMed |
| MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma. | Aging (Albany NY) | 2023 | 37390121 | PubTator, text mining | PubMed |
| Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR-1236-3p/FGF7 axis in breast cancer. | Thorac Cancer | 2023 | 37385973 | PubTator, text mining | PubMed |
| Simultaneous measurement of nascent transcriptome and translatome using 4-thiouridine metabolic RNA labeling and translating ribosome affinity purification. | Nucleic Acids Res | 2023 | 37378452 | PubTator, text mining | PubMed |
| The RNA-binding protein ZC3H11A interacts with the nuclear poly(A)-binding protein PABPN1 and alters polyadenylation of viral transcripts. | J Biol Chem | 2023 | 37356722 | PubTator, text mining | PubMed |
| Diagnostic and therapeutic potential of circular RNA in brain tumors. | Neurooncol Adv | 2023 | 37334165 | PubTator, text mining | PubMed |
| Vital roles of m5C RNA modification in cancer and immune cell biology. | Front Immunol | 2023 | 37325635 | PubTator, text mining | PubMed |
| EIF4a3-regulated circRABL2B regulates cell stemness and drug sensitivity of lung cancer via YBX1-dependent downregulation of MUC5AC expression. | Int J Biol Sci | 2023 | 37324942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=14